New video on RefluGTM Isorepair, the latest barrier treatment for gastroesophageal reflux

21 June 2021

Discover the innovative mechanism of action of RefluG™ Isorepair, a new patented substance-based medical device (class IIa) designed to quickly reduce gastroesophageal reflux symptoms.

Gastroesophageal reflux disease (GERD) represents a common condition affecting millions of people worldwide with a global prevalence of almost 15%, reaching values higher than 21% in Europe and 28% in the USA. The disruption of the physiological barrier of the esophageal mucosa due to the acid refluxate represents the basis of GERD pathogenesis.

The new video on RefluG™ Isorepair shows how it exerts a protective and regenerative effect on irritated esophageal mucosa. It coats and protects the esophageal mucosa sustaining the physiological healing process of damaged epithelium with mucoadhesive, protective and regenerative effects.

RefluG™ Isorepair is an effective and safe liquid gel preparation, watch the video and discover more about the product!


Stay updated on news

* indicates required